Literature DB >> 17405691

Systems biology, toxins, obesity, and functional medicine.

Mark Hyman1.   

Abstract

By recognizing the role of toxins in obesity and altered function of the neuro-endocrine-immune and mitochondrial and redox systems, and by creating a comprehensive strategy for both the reduction of exposure to and elimination of toxins, as well as the development of effective clinical strategies, treatment resistance in obesity may be more successfully addressed. Further research is needed to explore the clinical relevance and the mechanisms that underlie this hypothesis and to examine clinical detoxification methods. Through the prism of functional medicine, a context and road map exist for tackling many treatment-resistant and complex chronic diseases, including obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405691

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  3 in total

Review 1.  Minireview: Epigenetic programming of diabetes and obesity: animal models.

Authors:  Yoshinori Seki; Lyda Williams; Patricia M Vuguin; Maureen J Charron
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

Review 2.  Developmental programming of cardiovascular disorders: focus on hypertension.

Authors:  Sheba M J MohanKumar; Andrew King; Andrew C Shin; Madhu P Sirivelu; P S MohanKumar; Gregory D Fink
Journal:  Rev Endocr Metab Disord       Date:  2007-08-01       Impact factor: 6.514

3.  The role of genetic variation of human metabolism for BMI, mental traits and mental disorders.

Authors:  Johannes Hebebrand; Triinu Peters; Dick Schijven; Moritz Hebebrand; Corinna Grasemann; Thomas W Winkler; Iris M Heid; Jochen Antel; Manuel Föcker; Lisa Tegeler; Lena Brauner; Roger A H Adan; Jurjen J Luykx; Christoph U Correll; Inke R König; Anke Hinney; Lars Libuda
Journal:  Mol Metab       Date:  2018-04-03       Impact factor: 7.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.